Cargando…

SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis

Fibrosis is an underlying cause of cirrhosis and hepatic failure resulting in end stage liver disease with limited pharmacological therapeutic options. The beneficial effects of relaxin peptide treatment have been demonstrated previously in clinically relevant animal models of liver disease. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaftanovskaya, Elena, Ng, Hooi Hooi, Rivas, Bryan, Myhr, Courtney, Shupe, Thomas, Hu, Xin, Ferrer, Marc, Southall, Noel, Wilson, Kenneth, Marugan, Juan, Bishop, Colin, Agoulnik, Irina, Agoulnik, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Non-Steroid Hormone Signaling
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552156/ http://dx.doi.org/10.1210/js.2019-SAT-035

Ejemplares similares

Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290
por: Kaftanovskaya, Elena M., et al.
Publicado: (2017)

Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290
por: Huang, Zaohua, et al.
Publicado: (2015)

Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral Obstruction
por: Ng, Hooi Hooi, et al.
Publicado: (2021)

ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
por: Kocan, Martina, et al.
Publicado: (2017)

SAT-047 Disorders in Mice with Subclinical Hypothyroidism
por: Chen, Wenbin, et al.
Publicado: (2019)

SAT026 Melanocortin Receptors In The Earliest Chordates?
por: Ji, Ren-Lei, et al.
Publicado: (2023)

SAT-049 Growth Hormone Treatment in Mexican Turner's Syndrome
por: Bonilla, Paola, et al.
Publicado: (2019)

SAT-044 Diabetes Alters Ischemia-Induced Gene Expression
por: Ariganjoye, Folabi, et al.
Publicado: (2019)

SAT-032 In Vitro Characterization Of GPR101 Transcriptional Regulation
por: Trivellin, Giampaolo, et al.
Publicado: (2019)

SAT-038 Physiology of Mice Lacking All Four Adenosine Receptors
por: Xiao, Cuiying, et al.
Publicado: (2019)

SAT-029 Understanding The Functions Of Parp-1 In Embryonic Stem Cells
por: Jones, Aarin, et al.
Publicado: (2019)

SAT-034 Photometry Based Measurement of G Protein-Coupled Receptor-Mediated Signalling
por: Jones-Tabah, Jace, et al.
Publicado: (2019)

SAT-031 Understanding Gβγ Isoform Interactome Profiles in Fibrotic Gene Regulation
por: Bouazza, Celia, et al.
Publicado: (2019)

SAT029 Goldfish Phoenixin: Role In Feeding Control And Its Regulation At The Hepatic Level
por: Qin, Xiangfeng, et al.
Publicado: (2023)

SAT-040 Structural Mechanisms of Parathyroid Hormone (PTH) Binding to Receptor and Regulation of Endosomal Signaling
por: Clark, Lisa, et al.
Publicado: (2019)

SAT027 Novel Obesity-Associated Melanocortin 4 Receptor Variants Modulate Signaling Differently
por: Rodriguez Rondon, Alejandra V, et al.
Publicado: (2023)

SAT-045 Transient Developmental Hypothyroidism Results in Dysregulation of Neural Progenitors and Birth Defect Formation in Rats
por: O'Shaughnessy, Katherine, et al.
Publicado: (2019)

SAT-030 Role of PARP-1 in Regulating Cytokine-Mediated Pro-Inflammatory Transcriptional Responses in Macrophages
por: Gupte, Rebecca, et al.
Publicado: (2019)

SAT-050 Growth Hormone Receptor Polymorphism and Its Effects on Clinical and Biochemical Expression in Acromegalic Patients
por: Tetzlaff, Walter, et al.
Publicado: (2019)

SAT-048 A Map of Predicted Proteolytic Cleavage Products for the Soluble Human Protein Proteome: Intriguing Patterns
por: Campbell, Kenneth, et al.
Publicado: (2019)

SAT-046 Modulation of Histone 3 Acetylation and Methylation Enhances the Expression and Function of Npr1 in Haplotype Mice
por: Kumar, Prerna, et al.
Publicado: (2019)

SAT-033 Studying Cell-Context Specific Effects on the Function of the AT1R in iPSCs and Their Differentiated Derivatives
por: Bourque, Kyla, et al.
Publicado: (2019)

SAT-039 GNAS-miRNAs Are Likely Involved in the Phenotype of Patients with Pseudohypoparathyroidism 1B/iPPSD3
por: Hanna, Patrick, et al.
Publicado: (2019)

SAT-041 Bioinformatic Analysis of Human Cutaneous Melanomas Identifies Increased Mortality and Genetic Alterations in GH-responsive Tumors
por: Kruse, Colin P.S., et al.
Publicado: (2019)

SAT025 Characterization Of The Melatonin Type 1 Receptor / Cannabinoid Type 1 Receptor (MT1/CB1) Heteromers
por: Cui, Yuanxu, et al.
Publicado: (2023)

SAT-036 Extracellular Domain Calcium-Sensing Receptor (CaSR) Mutations Leading to Hypercalcemic and Hypocalcemic Disorders Cluster at the Homodimeric Interface
por: Olesen, Mie, et al.
Publicado: (2019)

SAT-042 Pituitary Expression Of Isl1 Prevents Ectopic, Foxa1 And Foxj1 Mediated Differentiation Of Progenitors Into Rathke’S Cleft Cysts
por: Camper, Sally, et al.
Publicado: (2019)

SAT-037 Functional Interplay between Distinct P-TEFb Complexes Following Endothelin or α(1)-Adrenergic Receptor Activation in Rat Cardiomyocytes
por: Martin, Ryan, et al.
Publicado: (2019)

SAT-043 A Trafficking Defective Mutant PROKR2, Identified In Patients With Hypogonadotropic Hypogonadism, Cycles Between Endoplasmic Reticulum (ER) And Golgi To Attenuate ER Stress
por: Song, Yong Bhum, et al.
Publicado: (2019)

SAT030 HM15912, A Novel Long-Acting GLP-2 Analog, Improves Intestinal Growth And Absorption Capacity In Rat Model Of Short Bowel Syndrome
por: Choi, Jaehyuk, et al.
Publicado: (2023)

PMON183 Impact of Small Negative Allosteric Modulators (NAM) of the Follicle-stimulating Hormone (FSH) Receptor on the Dynamics of the Transcriptome in Rat Granulosa Cells Exposed to Different FSH Glycosylation Variants.
por: Hernãndez-Ramírez, Laura, et al.
Publicado: (2022)

SAT028 Beneficial Effect On Intestinal Growth Of A Long-Acting GLP-2 Analog, HM15912, After Treatment Switching From Conventional GLP-2 Drug Or Other Long-Acting GLP-2 Analogs Under Clinical Development In Animal Model
por: Park, Cho Rong, et al.
Publicado: (2023)

Human GPR17 Nonsynonymous Variants Identified in Individuals with Metabolic Diseases Have Distinct Functional Signaling Profiles
por: Conley, Jason M, et al.
Publicado: (2021)

PMON184 Ligand-dependent interaction between phosphatidylcholine transfer protein and PPARδ: therapeutic implications for metabolic syndrome
por: Druzak, Samuel, et al.
Publicado: (2022)

LBMON186 Beta-agonist Profiling Reveals Novel Biased Signaling Phenotypes For The Beta 2-adrenergic Receptor With Implications In The Treatment Of Asthma
por: Pascali, Francesco D, et al.
Publicado: (2022)

LBMON185 Isthmin-1 As A Modulator Of Metabolic Health
por: Zhao, Meng, et al.
Publicado: (2022)

PSUN235 Dopamine-induced polyuria
por: Dejhansathit, Siroj, et al.
Publicado: (2022)

OR08-5 Associations Between Signal Transducer and Activator of Transcription (STAT) Mutations and Galactorrhea
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2022)

PMON181 RGS4 Is Essential For The Sympathetic Regulation of The Short-chain Fatty Acid Receptor FFAR3 In The Heart
por: Carbone, Alexandra, et al.
Publicado: (2022)

LBODP080 Mc3r Expression In Liver Tissue Is Partially Responsible For The Severity Of Murine MC3R Deficiency Associated Obesity
por: Jain, Arad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdc7via2skirdhi55pk65lnojv